FRANCESCA POLVERINO

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease HOUSTON, TX NPI 1760140420

General Payments — all program years on this page

$46,633.79

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 50
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $42,442.10 across 39 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $33,641.508
Travel and Lodging $7,443.299
Food and Beverage $1,357.3122

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
GENZYME CORPORATION $16,389.4315
Amgen Inc. $9,228.1810
AstraZeneca UK Limited $8,271.548
Regeneron Pharmaceuticals, Inc. $4,332.002
Acerta Pharma LLC $4,162.502
Regeneron Healthcare Solutions, Inc. $58.452

By program year

Program yearAmountRecords
2022 $300.065
2023 $3,891.636
2024 $42,442.1039

Records — PY2024 (39)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1093881393 AstraZeneca UK Limited $2,416.50 07/31/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1093905053 AstraZeneca UK Limited $58.97 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093928046 AstraZeneca UK Limited $4,284.07 10/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1093949367 AstraZeneca UK Limited $96.36 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093971383 AstraZeneca UK Limited $1,165.97 10/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1093986889 AstraZeneca UK Limited $76.78 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093997091 AstraZeneca UK Limited $113.92 10/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1094035576 AstraZeneca UK Limited $58.97 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104275317 AstraZeneca Pharmaceuticals LP $135.00 05/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104611334 AstraZeneca Pharmaceuticals LP $4,027.50 12/19/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1114138820 Regeneron Healthcare Solutions, Inc. $36.72 05/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114138822 Regeneron Healthcare Solutions, Inc. $21.73 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114403763 Regeneron Pharmaceuticals, Inc. $1,444.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1114403765 Regeneron Pharmaceuticals, Inc. $2,888.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1117657655 Amgen Inc. $5,256.00 06/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1117657657 Amgen Inc. $2,628.00 06/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1117657659 Amgen Inc. $236.22 04/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1117657661 Amgen Inc. $124.57 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117657663 Amgen Inc. $24.52 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117657665 Amgen Inc. $24.52 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117657667 Amgen Inc. $245.71 05/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1117657669 Amgen Inc. $33.63 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117657671 Amgen Inc. $587.69 05/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1117657673 Amgen Inc. $67.32 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139658372 GENZYME CORPORATION $39.86 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139658432 GENZYME CORPORATION $36.04 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139658446 GENZYME CORPORATION $550.80 03/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1139658448 GENZYME CORPORATION $150.48 03/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1139658450 GENZYME CORPORATION $108.43 03/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1139658452 GENZYME CORPORATION $112.16 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139658454 GENZYME CORPORATION $39.72 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139658456 GENZYME CORPORATION $64.37 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139658458 GENZYME CORPORATION $68.47 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139658460 GENZYME CORPORATION $12,274.00 03/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1139658484 GENZYME CORPORATION $28.81 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139658508 GENZYME CORPORATION $139.62 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139658522 GENZYME CORPORATION $2,707.50 09/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1139658524 GENZYME CORPORATION $12.77 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139658526 GENZYME CORPORATION $56.40 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.